![]() |
市場調查報告書
商品編碼
1662768
2030 年實驗室耗材市場預測:按產品類型、應用、最終用戶和地區進行的全球分析Lab Consumables Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球實驗室耗材市場預計在 2024 年將達到 135.2 億美元,預計到 2030 年將達到 197.3 億美元,預測期內的複合年成長率為 6.5%。實驗室中用於各種目的(例如工業測試、診斷、研究等)的一次性用品和設備稱為實驗室耗材。這包括試管、過濾器、移液器、玻璃器皿、塑膠器皿、試劑和手套等安全設備。需要實驗室消耗品來進行研究、分析樣本並維護實驗室的安全。這些消耗品設計用於一次性或短期使用,有助於維持實驗室活動的準確性、效率和衛生。
根據世界衛生組織(WHO)的數據,慢性病是造成全球71%死亡的原因,其中2019年心血管疾病導致的死亡佔所有死亡人數的31%。
診斷測試需求不斷增加
測試過程中使用的各種耗材的需求是實驗室耗材市場的主要驅動力,直接推動力是診斷測試需求的不斷成長。隨著人們越來越了解健康問題並尋求早期疾病診斷的診斷測試,試劑、檢測套組、樣本採集用品和實驗室消耗品的使用越來越頻繁。診斷檢測的增加也是感染疾病爆發、慢性病發展和預防性醫療保健的結果。為了滿足日益成長的檢測需求,診斷中心、醫院和實驗室需要穩定的消耗品供應。
一次性產品對環境的影響
實驗室耗材產業越來越關注一次性產品對環境的影響,因為微量吸管尖、試管和手套等一次性塑膠製品使用頻繁,產生大量廢棄物。這些消耗品在實驗室中大量生產,並經常被丟棄在垃圾掩埋場,增加了塑膠污染並破壞了環境。生產和處理這些產品需要耗費大量的能源和資源,這進一步加劇了環境問題。為了減少實驗室運作對環境的影響,同時保持測試的效率和安全性,人們越來越需要永續的替代品,例如可回收包裝、可重複使用的實驗室用具和生物分解性的材料。
增加研發投入
隨著生物技術、製藥、醫學和環境科學等領域大力投資研發新藥、診斷方法和新技術,對試劑、培養基、檢測套組和塑膠器皿等優質實驗室耗材的需求日益增加。這些消耗品對於各種實驗室測試、分析和實驗至關重要。此外,隨著基因組學、個人化醫療和分子研究的興起進一步刺激研發工作,實驗室需要穩定供應專業、可靠的消耗品來支持尖端的研究發現,實驗室消耗品市場將繼續成長。
供應鏈中斷
實驗室耗材產業供應鏈中斷可能會嚴重影響研究、診斷和醫療應用中使用的關鍵耗材的可用性和成本。對於試劑、玻璃器皿和移液器等消耗品,我們可能會因原料短缺、運輸延誤和物流困難等因素而出現庫存短缺或前置作業時間延長的情況。此外,這些中斷可能會增加生產商和最終用戶的實驗室消耗成本。此類中斷也可能影響依賴快速準確檢測的領域的醫療和科學進步的有效性,從而帶來進一步的市場挑戰。
COVID-19 的影響
COVID-19 疫情以多種方式影響了檢測耗材市場。一方面,診斷檢測特別是新冠病毒檢測的增加,增加了對檢測套組、試劑和個人防護設備等消耗品的需求。然而,物流挑戰、原料短缺和供應鏈延遲影響了關鍵測試耗材的及時供應。儘管存在這些障礙,但疫情刺激了診斷工具的創新,並凸顯了有效消耗品在醫療保健和研究中的重要性,從而推動市場持續擴張。
臨床診斷領域預計將成為預測期內最大的領域
由於對準確和及時的疾病診斷的需求不斷增加,特別是慢性病和感染疾病的增加,預計臨床診斷領域將在預測期內佔據最大的市場佔有率,這反過來又增加了對試劑、檢測套組和檢體市場佔有率材料等消耗品的需求。分子診斷和就地檢驗等診斷技術的進步進一步推動了實驗室消耗品的消費,支持了臨床診斷領域的擴張。
預計在預測期內,CRO(委外研發機構)部門的複合年成長率最高
由於外包臨床測試和研究計劃中使用的消耗品的需求不斷增加,預計委外研發機構(CRO)部門將在預測期內見證最高成長率。由於製藥、生物技術和醫療設備企業依賴 CRO 進行藥物開發、安全測試和法規遵循,對試劑、檢測套組、培養基和實驗室用具的需求日益增加。臨床測試和研發活動的成長進一步推動了 CRO 耗材市場的發展。
在預測期內,由於醫療保健基礎設施的擴大、研發投入的增加以及診斷測試的需求不斷成長,預計亞太地區將佔據最大的市場佔有率。中國、印度和日本等國家正在經歷實驗室活動的激增,尤其是在臨床診斷和生物技術領域。這種成長導致對試劑、檢測套組和實驗室設備等消耗品的需求增加,從而促進了該地區醫療保健和研究格局的不斷擴大。
預計北美地區在預測期內將呈現最高的複合年成長率。這是得益於強大的醫療保健系統、高額的研發投入以及不斷成長的診斷測試需求。慢性病的增加以及分子診斷和生物技術的進步正在推動對試劑、檢測套組和檢測設備等消耗品的需求。此外,已建立的醫療設施和研究機構網路進一步加速了該地區實驗室消耗品的消耗。
According to Stratistics MRC, the Global Lab Consumables Market is accounted for $13.52 billion in 2024 and is expected to reach $19.73 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Disposable supplies and equipment used in labs for a range of purposes, such as industrial testing, diagnostics, and research, are referred to as lab consumables. These include of things like test tubes, filters, pipettes, glassware, plastic-ware, reagents, and gloves and other safety gear. In order to conduct research, analyze samples, and maintain safety in lab settings, lab consumables are necessary. They are made to be used only once or for a brief period of time, which helps to preserve accuracy, efficiency, and hygiene in laboratory activities.
According to the World Health Organization (WHO), chronic diseases cause 71% of all deaths worldwide, with cardiovascular diseases accounting for 31% of all fatalities in 2019.
Rising demand for diagnostic testing
The requirement for different consumables used in testing processes is directly fueled by the growing need for diagnostic testing, which is a major driver of the lab consumables market. Reagents, test kits, sample collection supplies, and laboratory consumables are used increasingly frequently as a result of people seeking diagnostic testing for early illness diagnosis as health issues become more well known. The rise in diagnostic testing is also a result of infectious disease outbreaks, the development of chronic illnesses, and the movement toward preventative healthcare. To accommodate the increasing demand for testing, diagnostic centers, hospitals, and laboratories need a steady supply of consumables.
Environmental impact of disposable products
Concern over the environmental effects of disposable products in the lab consumables sector is developing since single-use plastic items like pipette tips, test tubes, gloves, are used so frequently and generate a lot of waste. Large amounts of these consumables are produced in laboratories and frequently wind up in landfills, increasing plastic pollution and degrading the environment. Environmental problems are made worse by the significant energy and resource requirements for the manufacture and disposal of these goods. To lessen the environmental impact of lab operations while preserving testing efficiency and safety, there is a growing movement for sustainable alternatives, such as recyclable packaging, reusable lab equipment, and biodegradable materials.
Growing research and development (R&D) investments
High-quality lab consumables, such as reagents, culture medium, test kits, and plasticware, are becoming more and more necessary as sectors including biotechnology, pharmaceuticals, healthcare, and environmental science make significant investments in research and development to create new medications, diagnostic techniques, and technologies. For testing, analysis, and experimentation in a wide range of research applications, these consumables are essential. Furthermore, as genomics, personalized medicine, and molecular research increase, R&D efforts are further stimulated, leading to the market for lab consumables to continue growing as labs need a consistent supply of specialized and dependable supplies to support cutting-edge research discoveries.
Supply chain disruptions
The availability and cost of crucial supplies used in research, diagnostics, and healthcare applications can be greatly impacted by supply chain interruptions in the lab consumables industry. For consumables like reagents, glassware, and pipettes, factors like shortages of raw materials, delays in transit and logistical difficulties can result in stock-outs and prolonged lead times. Furthermore, these disruptions may increase the cost of lab consumables for both producers and end users. Such disruptions may also affect the effectiveness of health care and scientific advancement in sectors that depend on prompt, accurate testing, posing further market challenges.
Covid-19 Impact
The COVID-19 pandemic affected the market for lab consumables in a variety of ways. The rise in diagnostic testing, particularly for the detection of COVID-19, has, on the one hand, raised demand for consumables such as test kits, reagents, and personal protective equipment. However, the timely availability of crucial lab consumables was impacted by logistical difficulties, raw material shortages, and supply chain delays. The pandemic, in spite of these obstacles, spurred diagnostic tool innovation and brought attention to the significance of effective consumables in medical and research contexts, which resulted in sustained market expansion.
The clinical diagnostics segment is expected to be the largest during the forecast period
The clinical diagnostics segment is expected to account for the largest market share during the forecast period, due to rising demand for accurate, timely disease diagnosis, especially with the rise in chronic conditions and infectious diseases, fuels the need for consumables like reagents, test kits, and sample collection materials. Advances in diagnostic technologies, such as molecular diagnostics and point-of-care testing, further boost the consumption of lab consumables, supporting the expansion of the clinical diagnostics sector.
The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the contract research organizations (CROs) segment is predicted to witness the highest growth rate, due to rising demand for consumables used in clinical trials and research projects that are outsourced. Reagents, test kits, culture media, and laboratory equipment are becoming more and more necessary as pharmaceutical, biotechnology, and medical device businesses depend on CROs for drug development, safety testing, and regulatory compliance. The market for consumables in CROs is further enhanced by the growth of clinical trials and R&D activities.
During the forecast period, Asia Pacific region is expected to hold the largest market share, driven by expanding healthcare infrastructure, increasing investments in research and development, and rising demand for diagnostic testing. Countries like China, India, and Japan are witnessing a surge in laboratory activities, particularly in clinical diagnostics and biotechnology sectors. This growth enhances the need for consumables such as reagents, test kits, and laboratory equipment, contributing to the region's expanding healthcare and research landscape.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong healthcare systems, high research and development investments, and growing diagnostic testing needs. The increasing prevalence of chronic diseases, along with advancements in molecular diagnostics and biotechnology, drives the demand for consumables like reagents, test kits, and lab equipment. Additionally, a well-established network of healthcare facilities and research institutions further accelerates the consumption of lab consumables in the region.
Key players in the market
Some of the key players profiled in the Lab Consumables Market include Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Corning Incorporated, Becton, Dickinson and Company (BD), Eppendorf AG, PerkinElmer, Inc., Sartorius AG, GE Healthcare Life Sciences, Lonza Group, Fisher Scientific, Waters Corporation, Labcon North America, Cell Signaling Technology, Inc., and SensoTech GmbH.
In January 2025, Merck, launched a beta version of M-Trust(TM), a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting.
In January 2025, Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation announced that they have formed an investment partnership with Innovaccer Inc., a leading healthcare artificial intelligence (AI) company.